MENU

SER Serina Therapeutics Forecast, Technical & Fundamental Analysis

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

SER is expected to report earnings to fall 45.45% to -30 cents per share on March 30

Serina Therapeutics SER Stock Earnings Reports
Q4'26
Est.
$-0.30
Q2'26
Missed
by $0.09
The last earnings report on August 13 showed earnings per share of -55 cents, missing the estimate of -46 cents. With 163.36K shares outstanding, the current market capitalization sits at 41.91M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAG15.510.41
+2.75%
Conagra Brands
AMZN260.21-5.82
-2.19%
Amazon.com
XBP2.90-0.07
-2.36%
XBP Global Holdings Inc.
SUPN26.74-1.47
-5.21%
Supernus Inc
ADUR9.10-0.77
-7.80%
Aduro Clean Technologies Inc

SER and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been loosely correlated with GERN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SER jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
-7.65%
GERN - SER
65%
Loosely correlated
+16.13%
XTLB - SER
59%
Loosely correlated
-4.47%
TOVX - SER
34%
Loosely correlated
+4.40%
LIFE - SER
34%
Loosely correlated
-9.17%
ATNM - SER
31%
Poorly correlated
+0.71%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-9630
Employees
16
Web
https://www.serinatherapeutics.com
Serina Therapeutics (SER) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com